- Received Nasdaq deficiency letter due to closing bid price remaining below $1.00 for 30 consecutive business days.
- Company risks delisting if minimum bid price is not regained within the compliance cure period.
- Potential need for a reverse stock split to regain compliance.
?? Negative AI Sentiment (-4.0 / 10)